Mohammad Jalili-Nik

12PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 06, 2026
Harnessing Repurposed Drugs to Enhance Temozolomide Efficacy in Glioblastoma.

|Jul 21, 2026
Drug repurposing as a promising therapeutic strategy against renal cell carcinoma.

|Feb 02, 2026
Gut Microbiome Strategies for Enhancing ICI Delivery Across the BBB in Glioblastoma.

Sama Barati, Sahar Ghoflchi, Ali Nakhaei

|Sep 15, 2025
Promising Cancer Vaccine for Glioblastoma Therapy: A Focus on mRNA Vaccine.

Sama Barati, Sahar Ghoflchi, Pejman Hosseinzadeh

|Nov 07, 2023
Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy.

Baratali Mashkani, Mohammad Jalili Nik, Seyed Abdolrahim Rezaee

|Aug 09, 2023
Urolithin B inhibits proliferation and migration and promotes apoptosis and necrosis by inducing G2/M arrest and targeting MMP-2/-9 expression in osteosarcoma cells.

Nahid Tajvar Nasab, Mohammad Jalili-Nik, Amir R Afshari

Pageof 2

Frequent Collaborators

3 joint publications

Baratali Mashkani

2 joint publications

Mohammad Soukhtanloo

2 joint publications

Ali Nakhaei

2 joint publications

Ali Gorji